[Clinical and electroencephalographic results of a double-blind test with vincamine (Pervincamine) in advanced cerebral sclerosis (author's transl)].
D000328:Adult; D000368:Aged; D001930:Brain Injuries / Q000188:drug therapy; D002318:Cardiovascular Diseases / Q000188:drug therapy; D002986:Clinical Trials as Topic; D003863:Depression / Q000188:drug therapy; D002549:Diffuse Cerebral Sclerosis of Schilder / Q000188:drug therapy*; D004569:Electroencephalography; D005260:Female; D006801:Humans; D008297:Male; D008568:Memory / Q000187:drug effects; D008875:Middle Aged; D009042:Motivation / Q000187:drug effects; D009129:Muscle Tonus / Q000187:drug effects; D012018:Reflex / Q000187:drug effects; D012677:Sensation / Q000187:drug effects; D012919:Social Behavior / Q000187:drug effects; D013223:Statistics as Topic; D013850:Thinking / Q000187:drug effects; D014748:Vinca Alkaloids / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*
D014748:Vinca Alkaloids
Klinische und elektroenzephalographische Ergebnisse eines Doppelblindversuches mit Vincamin (Pervincamin) bei fortgeschrittener Zerebralsklerose